Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs With Outperform Rating, Announces Price Target of $8
Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs With Outperform Rating, Announces Price Target of $8
Northland Capital Markets啓動了對評級跑贏大盤的Cardio Diagnostics控股的報道，宣佈目標股價爲8美元
Northland Capital Markets analyst Carl Byrnes initiates coverage on Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Outperform rating and announces Price Target of $8.
Northland Capital Markets分析師卡爾·伯恩斯以跑贏大盤的評級開始對Cardio Diagnostics Hldgs（納斯達克股票代碼：CDIO）進行報道，並宣佈目標股價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。